We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
ARK Genomic Revolution ETF
ARKG
$1.54B
| $808K | 0.01% |
8,740
+1,240
| +17% | +$105K |
|
727
Domino's
DPZ
$11.4B
| $807K | 0.01% |
1,731
-10,308
| -86% | -$4.37M |
|
728
Sprouts Farmers Market
SFM
$7.23B
| $801K | 0.01% |
+32,221
| New | +$860K |
|
729
Cognex
CGNX
$10.2B
| $799K | 0.01% |
9,505
+1,397
| +17% | +$113K |
|
730
Fidelity National Financial
FNF
$14B
| $796K | 0.01% |
19,043
+3,400
| +22% | +$148K |
|
731
Elanco Animal Health
ELAN
$12.7B
| $780K | 0.01% |
22,491
+651
| +3% | +$21.5K |
|
732
Suncor Energy
SU
$75.6B
| $775K | 0.01% |
32,317
-18,536
| -36% | -$425K |
|
|
ZEN
733
DELISTED
ZENDESK INC
ZEN
| $775K | 0.01% |
5,369
+2,099
| +64% | +$296K |
|
734
Campbell Soup
CPB
$6.67B
| $773K | 0.01% |
16,950
-129,773
| -88% | -$6.25M |
|
|
LSXMK
735
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $771K | 0.01% |
21,446
+456
| +2% | +$15.7K |
|
736
Teck Resources
TECK
$29.3B
| $767K | 0.01% |
33,272
+3,137
| +10% | +$71.4K |
|
737
Apollo Global Management
APO
$71.6B
| $762K | 0.01% |
12,250
-5,320
| -30% | -$295K |
|
738
Molson Coors Class B
TAP
$7.71B
| $759K | 0.01% |
14,134
-2,724
| -16% | -$152K |
|
739
Wheaton Precious Metals
WPM
$50.9B
| $749K | 0.01% |
16,990
+5,799
| +52% | +$258K |
|
740
Franco-Nevada
FNV
$41.4B
| $733K | 0.01% |
5,045
-1,141
| -18% | -$165K |
|
|
AVLR
741
DELISTED
Avalara, Inc.
AVLR
| $730K | 0.01% |
4,510
| – | – |
|
742
Western Union
WU
$2.55B
| $728K | 0.01% |
31,709
+1,424
| +5% | +$35.5K |
|
743
10x Genomics
TXG
$5.83B
| $720K | ﹤0.01% |
+3,676
| New | +$665K |
|
744
Canadian Natural Resources
CNQ
$93.4B
| $699K | ﹤0.01% |
39,298
-15,119
| -28% | -$249K |
|
745
Molina Healthcare
MOH
$10.4B
| $674K | ﹤0.01% |
2,662
+26
| +1% | +$6.53K |
|
|
DAY
746
DELISTED
Dayforce
DAY
| $674K | ﹤0.01% |
7,025
-43
| -0.6% | -$3.88K |
|
747
Cboe Global Markets
CBOE
$30.2B
| $670K | ﹤0.01% |
5,631
-2,331
| -29% | -$256K |
|
748
iShares Semiconductor ETF
SOXX
$42.7B
| $668K | ﹤0.01% |
+4,410
| New | +$631K |
|
749
Sunrun
RUN
$2.38B
| $665K | ﹤0.01% |
+11,917
| New | +$575K |
|
|
COOP
750
DELISTED
Mr. Cooper
COOP
| $664K | ﹤0.01% |
+20,096
| New | +$671K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.